Evidence map›Paper›PMID 29299379›Full record

ArticleBrain and behavior2017

Headache in the first manifestation of Multiple Sclerosis - Prospective, multicenter study.

Marcel Gebhardt, Peter Kropp, Tim P Jürgens, Frank Hoffmann, Uwe K Zettl

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Brain and behavior, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. [Headache in multiple sclerosis].Der Nervenarzt · 2020
    Review
  8. Review
  9. Headache and Its Management in Patients With Multiple Sclerosis.Current treatment options in neurology · 2018
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Marcel GebhardtKrankenhaus Martha-Maria Halle-Dölau Halle Germany.ORCID 0000-0001-9318-3480
Peter KroppInstitute of Medical Psychology and Medical Sociology Medical Faculty University of Rostock Rostock Germany.
Tim P JürgensDepartment of Neurology University Medical Center Rostock Rostock Germany.
Frank HoffmannKrankenhaus Martha-Maria Halle-Dölau Halle Germany.
Uwe K ZettlDepartment of Neurology Neuroimmunological Section University of Rostock Rostock Germany.
University of Rostock · DEMartha-Maria Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Multiple sclerosis (MS) is the most frequent immune-mediated inflammation of the central nervous system that can lead to early disability. Headaches have not been considered as MS-related symptoms initially, whereas higher prevalence rates were reported since 2000. Postmortem histological analyses of MS patients' brains revealed lymphoid follicle-like structures in the cerebral meninges which suggest a possible pathophysiological explanation for the high headache prevalence in MS. The aim of this study was to evaluate headache characteristics during the first clinical event of MS. Methods: In a prospective, multicenter study, 50 patients with the diagnosis of CIS or MS were recruited. All participants were screened for the presence of headache within the last 4 weeks with help of the Rostock Headache Questionnaire (Rokoko). Results: Thirty-nine of fifty questioned patients (78%) reported headaches within the last 4 weeks. Most patients suffered from throbbing and pulsating headaches (25, 50%), 15 (30%) reported stabbing, 14 (28%) dull and constrictive headaches. Conclusions: Headaches were prevalent in 78% of patients in our population with newly diagnosed CIS and MS. It is among the highest prevalence rates reported so far in patients with CIS or MS. Thus, headache, especially of a migraneous subtype, is a frequent symptom within the scope of the first manifestation of multiple sclerosis. If it were possible to define a MS-typical headache, patients with these headaches and with typical MRI results would be classified as CIS or early MS instead of radiologically isolated syndrome and treated accordingly with an immunomodulatory therapy.

Indexed as

AdultBrain DiseasesFemaleHeadache DisordersHumansMagnetic Resonance ImagingMaleMeningitisMultiple SclerosisProspective StudiesSurveys and Questionnairesclinically isolated syndromeheadachemigrainemultiple sclerosisradiologically isolated syndrome

Identifiers

PMID29299379
PMCPMC5745239
OpenAlexW2770891796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.